TNFRSF13B and Miyoshi myopathy: In addition, the killing of BCMA+TACI+ cells by ACAR-T cells was not affected by an anti-BCMA blocking antibody, indicating that ACAR-T cells could maintain MM-killing efficacy possibly by targeting TACI on MM cells even when BCMA is downregulated.